Synedica BPC 157 & TB 500 40mg Pen is a research-grade peptide combination designed for laboratory studies focusing on recovery, repair mechanisms, and tissue-regeneration pathways.

BPC-157 is commonly referenced in research involving soft tissue recovery, gastrointestinal pathway modelling, and cellular repair signalling. TB-500 (Thymosin Beta-4 fragment) is widely studied for its role in cellular migration, wound healing models, and recovery-related processes.

When combined, these peptides are frequently examined for synergistic effects in:

• Tissue regeneration and repair modelling
• Recovery and healing pathway observation
• Inflammation-response research
• Cellular signalling and repair mechanisms

The precision pen delivery system allows structured and consistent administration within research environments, supporting accurate observation of peptide interaction and recovery response patterns.

Each kit includes a prefilled pen, disposable needles, and an instruction booklet for laboratory handling.

Key Features

Synedica BPC 157 & TB 500 40mg Pen

• Dual peptide formulation (BPC-157 30% & TB-500 70%)
• Examined for tissue repair and recovery modelling
• 40mg total content (4 × 10mg doses)
• Precision injection pen delivery system
• Supplied with needles and instruction booklet

How to Use (Research Reference Only)

Research literature evaluates peptide combinations using structured protocols in controlled laboratory environments.

This information is provided for scientific reference only and is not guidance for human use.

Stacking (Research Context)

In laboratory environments, this peptide combination may be examined alongside:

• Growth hormone pathway research compounds
• NAD+ or mitochondrial studies
• Recovery and anti-ageing research models

Stacking depends entirely on experimental design.

Research Disclaimer

For laboratory and scientific research use only.(Synedica BPC 157 & TB 500 40mg Pen)
Not intended for human consumption, medical treatment, or veterinary application.